Features
Rebecca Pender’s daughter Hannah lives with the ultra-rare condition Inv Dup Del 8p, a genetic arrangement that affects just 80 people worldwide....
In often tough regulatory climates and with threats to public health are growing in sceptical corners of society, the need to deliver treatments...
Louis Goss talks to Harvard Medical School placebo expert Dr Ted Kaptchuk in asking what the placebo effect means for doctors,...
“I’m fascinated by science…I’m amazed by the explosion of knowledge”
Though often necessary, internal investigations are seldom smooth or easy. Rosanne Kay, Partner at law firm Reed Smith, outlines a robust strategy...
Alison Hollands, Vice President, Respiratory, UK Pharmaceuticals at GlaxoSmithKline, addresses the importance of implementing the latest...
Dan Jeffries was diagnosed with the ultra-rare condition Wyburn-Mason syndrome at a young age, leaving him blind in one eye. But this occurrence,...
Louis Goss asks what the future might hold for the safety of pharmaceuticals and looks into why crucial pharmacovigilance practices offer...
While immunotherapies continue to be the darling of the industry, new, innovative and sometimes seemingly fantastical research is emerging that...
Nicola Redfern discusses her career aspirations as she moved through major industry players like Novartis, Sanofi, MSD and Celgene, her leap to...